All Neurology and Pain Management providers, NPs, PAs,CRCs, are invited to join us to learn more about the history of neuromodulation, it’s role in treating Chronic Migraineand to review the exciting upcoming RELIEV-CM2 study.
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
